A fresh look at dry weight

Hemodialysis International

Volumn 12, Issue 4, 2008, Pages 395-405

  Raimann, Jochen ^a,b   Liu, Li ^a,b   Tyagi, Sudhi ^a   Levin, Nathan W ^a   Kotanko, Peter ^a  

^a RENAL RESEARCH INSTITUTE   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Bioimpedance; Dry weight; Hemodialysis; Interstitial fluid; Lymphatic system; Plasma refilling

Indexed keywords

SODIUM;

ANALYTIC METHOD; BIOIMPEDANCE; BLOOD VOLUME; CENTRAL VENOUS PRESSURE; DIETARY INTAKE; DRY WEIGHT; EXTRACELLULAR FLUID; EXTRACELLULAR SPACE; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HUMAN; HYDRATION; HYPERTENSION; HYPOTENSION; INTERSTITIAL FLUID; KIDNEY FAILURE; LEAN BODY WEIGHT; LYMPH FLOW; LYMPHATIC SYSTEM; OVERHYDRATION; OXIDATIVE STRESS; PATIENT CARE; PATIENT COUNSELING; PHYSICAL DISEASE BY COMPOSITION OF BODY FLUIDS, EXCRETA AND SECRETIONS; REVIEW; SALT INTAKE; SODIUM BALANCE; SODIUM RESTRICTION; ULTRAFILTRATION; WATER CONTENT;

BODY WEIGHT; HUMANS; HYPOTENSION; KIDNEY FAILURE, CHRONIC; LYMPHATIC SYSTEM; MODELS, BIOLOGICAL; RENAL DIALYSIS;

EID: 53549104432     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2008.00302.x     Document Type: Review

References (61)

1. Thomson GE, Waterhouse K, McDonald HP Jr., Friedman EA. Hemodialysis for chronic renal failure. Clinical observations. Arch Intern Med. 1967; 120: 153-167.
2. Daugirdas JT, Blake PG, Ing TS. Handbook of Dialysis. Baltimore (MD), Lippincott Williams; 2007.
3. Geers AB, Koomans HA, Roos JC, Dorhout Mees EJ. Preservation of blood volume during edema removal in nephrotic subjects. Kidney Int. 1985; 28: 652-657.
4. Koomans HA, Braam B, Geers AB, Roos JC, Dorhout Mees EJ. The importance of plasma protein for blood volume and blood pressure homeostasis. Kidney Int. 1986; 30: 730-735.
5. Aukland K, Reed RK. Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. Physiol Rev. 1993; 73: 1-78.
6. Tyagi S, Thijssen S, Kotanko P, Levin NW. Plasma refilling during ultrafiltration in hemodialysis patients: A potential role for the lymphatic system [abstract]. ASN Renal Week 2008, November 4-9, 2008, Philadelphia, PA.
7. Harper SJ, Tomson CR, Bates DO. Human uremic plasma increases microvascular permeability to water and proteins in vivo. Kidney Int. 2002; 61: 1416-1422.
8. Guyton AC, Hall JE. Textbook of Medical Physiology. Philadelphia (PA): Elsevier Saunders; 2006.
9. Brace RA, Power GG. Thoracic duct lymph flow and protein flux dynamics: Responses to intravascular saline. Am J Physiol. 1981; 240: R282-R288.
10. Szabo G, Magyar Z. Effect of increased systemic venous pressure on lymph pressure and flow. Am J Physiol. 1967; 212: 1469-1474.
11. Tanra A. Studies on the contraction of rat mesentery lymphatic vessels. II. Effect of catecholamines on the rat mesentery lymphatic vessels. Hiroshima J Anesth. 1980; 16: 147-158.
12. Beninson J, Levin NW, Santiago G, Paparao P, Bobola N. Use of intermittent pneumatic compression in hemodialysis. Proc Clin Dial Transplant Forum. 1974; 4: 209-213.
13. Stewart JM, Karman C, Montgomery LD, McLeod KJ. Plantar vibration improves leg fluid flow in perimenopausal women. Am J Physiol Regul Integr Comp Physiol. 2005; 288: R623-R629.
14. Charra B, Calemard M, Laurent G. Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol. 1996; 16: 35-44.
15. Scribner BH, Buri R, Caner JE, Hegstrom R, Burnell JM. The treatment of chronic uremia by means of intermittent hemodialysis: A preliminary report. Trans Am Soc Artif Intern Organs. 1960; 6: 114-122.
16. Chien S, Li S, Shyy YJ. Effects of mechanical forces on signal transduction and gene expression in endothelial cells. Hypertension. 1998; 31(Pt 2): 162-169.
17. Shi-Wen X, Denton CP, Dashwood MR, et al. Fibroblast matrix gene expression and connective tissue remodeling: Role of endothelin-1. J Invest Dermatol. 2001; 116: 417-425.
18. Kitiyakara C, Chabrashvili T, Chen Y, et al. Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J Am Soc Nephrol. 2003; 14: 2775-2782.
19. Sanders PW. Salt intake, endothelial cell signaling, and progression of kidney disease. Hypertension. 2004; 43: 142-146.
20. Verhave JC, Hillege HL, Burgerhof JG, et al. Sodium intake affects urinary albumin excretion especially in overweight subjects. J Intern Med. 2004; 256: 324-330.
21. Joffe HV, Adler GK. Effect of aldosterone and mineralocorticoid receptor blockade on vascular inflammation. Heart Fail Rev. 2005; 10: 31-37.
22. Wang AY, Lai KN. The importance of residual renal function in dialysis patients. Kidney Int. 2006; 69: 1726-1732.
23. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension. 1986; 8(Pt 2): 127-II134.
24. Skrabal F, Kotanko P, Luft FC. Inverse regulation of alpha-2 and beta-2 adrenoceptors in salt-sensitive hypertension: An hypothesis. Life Sci. 1989; 45: 2061-2076.
25. Flier JS, Maratos-Flier E, Pallotta JA, McIsaac D. Endogenous digitalis-like activity in the plasma of the toad Bufo marinus. Nature. 1979; 279: 341-343.
26. Stella P, Manunta P, Mallamaci F, et al. Endogenous ouabain and cardiomyopathy in dialysis patients. J Intern Med. 2008; 263: 274-280.
27. Fedorova OV, Zhuravin IA, Agalakova NI, et al. Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na/K-ATPase inhibitor. J Hypertens. 2007; 25: 1834-1844.
28. Bagrov AY, Shapiro JI. Endogenous digitalis: Pathophysiologic roles and therapeutic applications. Nat Clin Pract Nephrol. 2008; 4: 378-392.
29. Stamler J, Rose G, Elliott P, et al. Findings of the International Cooperative INTERSALT Study. Hypertension. 1991; 17(Suppl): I9-I15.
30. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997; 336: 1117-1124.
31. Sandek A, Bauditz J, Swidsinski A, et al. Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol. 2007; 50: 1561-1569.
32. Avila-Diaz M, Ventura MD, Valle D, et al. Inflammation and extracellular volume expansion are related to sodium and water removal in patients on peritoneal dialysis. Perit Dial Int. 2006; 26: 574-580.
33. Kotanko P, Carter M, Levin NW. Intestinal bacterial microflora - A potential source of chronic inflammation in patients with chronic kidney disease. Nephrol Dial Transplant. 2006; 21: 2057-2060.
34. Niebauer J, Volk HD, Kemp M, et al. Endotoxin and immune activation in chronic heart failure: A prospective cohort study. Lancet. 1999; 353: 1838-1842.
35. King D, Smith ML, Chapman TJ, Stockdale HR, Lye M. Fat malabsorption in elderly patients with cardiac cachexia. Age Ageing. 1996; 25: 144-149.
36. King D, Smith ML, Lye M. Gastro-intestinal protein loss in elderly patients with cardiac cachexia. Age Ageing. 1996; 25: 221-223.
37. Ozkahya M, Ok E, Cirit M, et al. Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol Dial Transplant. 1998; 13: 1489-1493.
38. Charra B, Bergstrom J, Scribner BH. Blood pressure control in dialysis patients: Importance of the lag phenomenon. Am J Kidney Dis. 1998; 32: 720-724.
39. Borst JG, Molhuysen JA. Exact determination of the central venous pressure by a simple clinical method. Lancet. 1952; 2: 304-309.
40. Mandelbaum A, Ritz E. Vena cava diameter measurement for estimation of dry weight in haemodialysis patients. Nephrol Dial Transplant. 1996; 11(Suppl 2): 24-27.
41. Chamney PW, Kramer M, Rode C, Kleinekofort W, Wizemann V. A new technique for establishing dry weight in hemodialysis patients via whole body bioimpedance. Kidney Int. 2002; 61: 2250-2258.
42. Piccoli A, Rossi B, Pillon L, Bucciante G. A new method for monitoring body fluid variation by bioimpedance analysis: The RXc graph. Kidney Int. 1994; 46: 534-539.
43. Piccoli A. Whole body - Single frequency bioimpedance. Contrib Nephrol. 2005; 149: 150-161.
44. Moissl UM, Wabel P, Chamney PW, et al. Body fluid volume determination via body composition spectroscopy in health and disease. Physiol Meas. 2006; 27: 921-933.
45. Wizemann V, Rode C, Wabel P. Whole-body spectroscopy (BCM) in the assessment of normovolemia in hemodialysis patients. Contrib Nephrol. 2008; 161: 115-118.
46. Zhu F, Kuhlmann MK, Sarkar S, et al. Adjustment of dry weight in hemodialysis patients using intradialytic continuous multifrequency bioimpedance of the calf. Int J Artif Organs. 2004; 27: 104-109.
47. Zhu F, Kuhlmann MK, Kotanko P, Seibert E, Leonard EF, Levin NW. A method for the estimation of hydration state during hemodialysis using a calf bioimpedance technique. Physiol Meas. 2008; 29: S503-S516.
48. Zhu F, Sarkar S, Kaitwatcharachai C, Greenwood R, Ronco C, Levin NW. Methods and reproducibility of measurement of resistivity in the calf using regional bioimpedance analysis. Blood Purif. 2003; 21: 131-136.
49. Zhu F, Kuhlmann MK, Kaysen GA, et al. Segment-specific resistivity improves body fluid volume estimates from bioimpedance spectroscopy in hemodialysis patients. J Appl Physiol. 2006; 100: 717-724.
50. Zhu F, Leonard EF, Carter M, Levin NW. Continuous measurement of calf resistivity in hemodialysis patients using bioimpedance analysis. Conf Proc IEEE Eng Med Biol Soc. 2006; 1: 5126-5128.
51. Chazot C, Charra B, Vo Van C, et al. The Janus-faced aspect of 'dry weight.' Nephrol Dial Transplant. 1999; 14: 121-124.
52. Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis: Off J Nat Kidney Fdn. 2006; 48: S2-S90.
53. Cook NR, Cutler JA, Obarzanek E, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: Observational follow-up of the trials of hypertension prevention (TOHP). BMJ. 2007; 334: 885.
54. Stiller S, Bonnie-Schorn E, Grassmann A, Uhlenbusch-Korwer I, Mann H. A critical review of sodium profiling for hemodialysis. Semin Dial. 2001; 14: 337-347.
55. Song JH, Park GH, Lee SY, Lee SW, Kim MJ. Effect of sodium balance and the combination of ultrafiltration profile during sodium profiling hemodialysis on the maintenance of the quality of dialysis and sodium and fluid balances. J Am Soc Nephrol. 2005; 16: 237-246.
56. Keen ML, Gotch FA. The association of the sodium "setpoint" to interdialytic weight gain and blood pressure in hemodialysis patients. Int J Artif Organs. 2007; 30: 971-979.
57. Maggiore Q, Pizzarelli F, Sisca S, et al. Blood temperature and vascular stability during hemodialysis and hemofiltration. Trans Am Soc Artif Intern Organs. 1982; 28: 523-527.
58. van der Sande FM, Kooman JP, van Kuijk WH, Leunissen KM. Management of hypotension in dialysis patients: Role of dialysate temperature control. Saudi J Kidney Dis Transpl. 2001; 12: 382-386.
59. Maggiore Q, Pizzarelli F, Santoro A, et al. The effects of control of thermal balance on vascular stability in hemodialysis patients: Results of the European randomized clinical trial. Am J Kidney Dis. 2002; 40: 280-290.
60. Nette RW, Krepel HP, van den Meiracker AH, Weimar W, Zietse R. Specific effect of the infusion of glucose on blood volume during haemodialysis. Nephrol Dial Transplant. 2002; 17: 1275-1280.
61. Saran R, Bragg-Gresham JL, Levin NW, et al. Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reduced mortality in the DOPPS. Kidney Int. 2006; 69: 1222-1228.